Return on average equity - 5 year average | -4.10 |
Net Income/employee - trailing 12 month | 5,62,003.30 |
Revenue/employee - most recent fiscal year | 1,36,97,800.00 |
Return on investment - most recent fiscal year | -4.43 |
Return on average assets - most recent fiscal year | -2.38 |
Receivables turnover - most recent fiscal year | 3.31 |
Return on investment - trailing 12 month | 5.43 |
Return on average assets - trailing 12 month | 2.79 |
Inventory turnover - most recent fiscal year | 1.56 |
Inventory turnover - trailing 12 month | 1.50 |
Revenue/employee - trailing 12 month | 1,43,89,290.00 |
Return on average assets - 5 year average | -1.68 |
Net Income/employee - most recent fiscal year | -5,02,228.20 |
Return on average equity - trailing 12 month | 8.19 |
Receivables turnover - trailing 12 month | 3.57 |
Asset turnover - most recent fiscal year | 0.65 |
Asset turnover - trailing 12 month | 0.72 |
Return on average equity - most recent fiscal year | -5.76 |
Return on investment - 5 year average | -2.97 |
Strides Pharma Science Dividend Strides Pharma Science Bonus Strides Pharma Science News Strides Pharma Science AGM Strides Pharma Science Rights Strides Pharma Science Splits Strides Pharma Science Board Meetings Strides Pharma Science Shareholdings Strides Pharma Science Profit Loss Strides Pharma Science Balance Sheet Strides Pharma Science Cashflow Strides Pharma Science Q1 Results Strides Pharma Science Q2 Results Strides Pharma Science Q3 Results Strides Pharma Science Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks